罗非考昔 Rofecoxib ; Vioxx
西非考试委员会 WAECWest African Examinations Council
非考上研究生 graduate non- matriculated
非参考单端 NRSE
参考非功能需求测试 non-functional requirements testing
是非题的考试 true-false test
非罗考昔 Firocoxib
非洲大陆参考系 AFREF African Continental Reference System
非标准化考试 non-standardized test
非法的考古学家 Illegal Archaeologists
该研究也支持以前关于罗非考昔（Vioxx）与心血管副作用相关的结论。
The findings also support prior research linking rofecoxib (Vioxx) with adverse cardiovascular effects.
罗非考昔能显著增加腹泻和降低便秘、疲劳、发热、体重减轻、疼痛和止痛剂消耗发生率。
Rofecoxib significantly increased the incidence of diarrhoea and decreased constipation, fatigue, fever, weight loss, and pain, and analgesic consumption.
罗非考昔可提高患者治疗反应率和数个生活质量项目，包括疼痛相关项目和总的生活质量。
Rofecoxib improved response rate and several quality-of-life items, including pain-related items and global quality of life.
应用推荐